MGMathew Golding

Mathew Golding

*This is an algorithmically generated author record based on publicly available information.

Mathew Golding has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A resource-efficient structure-based workflow for fragment progression enables parallel hit discovery and validation of functionally diverse modulators of NCS-1 protein–protein interactions

    by Daniel Muñoz-Reyes, Kate K. Fieseler, Max Winokan, Mathew Golding, Eda Capkin, Matteo Ferla, Sara Pérez-Suárez, Charlie W. E. Tomlinson, Peter G. Marples, Celia Miró-Rodríguez, et al.

    A data-driven, automation-assisted, customizable framework for fragment-to-hit progression that directly delivers structurally validated hit series primed for rapid SAR exploration and exploits high-throughput crystallography at synchrotrons.


  • Open Access

    Dengue virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Dengue virus (DENV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged DENV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Zika virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Coxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v2

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Zika virus NS2B-NS3 protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS2B-NS3 protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS2B-NS3 protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2

    by Milo Cooper, Anu V. Chandran, Charlotte Chinn, Mathew Golding, Peter Marples, Ali Ebrahim, Tracy Keates, Warren Thompson, Jasmin Aschenbrenner

    This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cut-offs, rationale, and GitHub repo for the code utilised during analysis are included. This version updates the old spreadsheet-based analysis with a Python program using pandas dataframes, XtalControl. (v.02 at time of writing) https://github.com/xchem/XtalControl

  • Open Access

    Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2

    by Milo Cooper, Anu V. Chandran, Charlotte Chinn, Mathew Golding, Peter Marples, Warren Thompson, Jasmin Aschenbrenner, Ali Ebrahim, Tracy Keates

    This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.

  • Open Access

    Coxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface via biotinylation. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).


  • Open Access

    Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening. v1

    by Milo Cooper, Anu V. Chandran, Charlotte Chinn, Mathew Golding, Peter Marples, Warren Thompson, Jasmin Aschenbrenner

    This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory and Protein Crystallisation Facility at Diamond Light Source. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.

  • Open Access

    Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement

    by Daren Fearon, Ailsa Powell, Alice Douangamath, Alexandre Dias, Charles W. E. Tomlinson, Blake H. Balcomb, Jasmin C. Aschenbrenner, Anthony Aimon, Isabel A. Barker, Felicity Bertram, et al.

    Fragment‐based drug discovery is a well‐established method for the identification of chemical starting points for development into clinical candidates. Historically, crystallographic fragment screening was perceived to be low‐throughput and time consuming. However, thanks to advances in synchrotron capabilities and the introduction of dedicated facilities, such as the XChem platform at Diamond Light Source, there have been substantial improvements in throughput and integration between sample preparation, data collection and hit identification. Herein we share our experiences of establishing a crystallographic fragment screening facility, our learnings from operating a user programme for ten years and our perspective on applying structural enablement to rapidly progress initial fragment hits to lead‐like molecules.